NASH (Non-Alcoholic Steatohepatitis) Market Report

China NASH (Non-Alcoholic Steatohepatitis) Industry Market Research Report 2023-2029

  • POSTDATE：Sep 29, 2023
  • PAGES：210
  • REPORT CODE：GMM1818144
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the NASH (Non-Alcoholic Steatohepatitis) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Prometheus Laboratories

    • Cadila Pharmaceuticals Ltd

    • BioPredictive SAS

    • Novartis AG

    • Intercept Pharmaceuticals, Inc

    • Genfit SA

    • Laboratory Corporation of America Holdings

    • Galmed Pharmaceuticals

    • One Way Liver, SL

    By Type:

    • Elafibranor

    • Others

    • Ocaliva

    • Selonsertib

    • Vitamin E & Pioglitazone

    • Cencicriviroc

    By Application:

    • Retail Pharmacy

    • Hospital Pharmacy

    • Online Provider

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China NASH (Non-Alcoholic Steatohepatitis) Market Overview 2018-2029

    • 1.1 China NASH (Non-Alcoholic Steatohepatitis) Industry Development Overview

    • 1.2 China NASH (Non-Alcoholic Steatohepatitis) Industry Development History

    • 1.3 China NASH (Non-Alcoholic Steatohepatitis) Industry Market Size (2018-2029)

    • 1.4 China NASH (Non-Alcoholic Steatohepatitis) Market Analysis by Type from Production Side

      • 1.4.1 China NASH (Non-Alcoholic Steatohepatitis) Production Volume, Production Value and Growth Rate of Elafibranor (2018-2029)

      • 1.4.2 China NASH (Non-Alcoholic Steatohepatitis) Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.3 China NASH (Non-Alcoholic Steatohepatitis) Production Volume, Production Value and Growth Rate of Ocaliva (2018-2029)

      • 1.4.4 China NASH (Non-Alcoholic Steatohepatitis) Production Volume, Production Value and Growth Rate of Selonsertib (2018-2029)

      • 1.4.5 China NASH (Non-Alcoholic Steatohepatitis) Production Volume, Production Value and Growth Rate of Vitamin E & Pioglitazone (2018-2029)

      • 1.4.6 China NASH (Non-Alcoholic Steatohepatitis) Production Volume, Production Value and Growth Rate of Cencicriviroc (2018-2029)

    • 1.5 China NASH (Non-Alcoholic Steatohepatitis) Market Analysis by Application from Consumption End

      • 1.5.1 China NASH (Non-Alcoholic Steatohepatitis) Sales Volume, Sales Value and Growth Rate of Retail Pharmacy (2018-2029)

      • 1.5.2 China NASH (Non-Alcoholic Steatohepatitis) Sales Volume, Sales Value and Growth Rate of Hospital Pharmacy (2018-2029)

      • 1.5.3 China NASH (Non-Alcoholic Steatohepatitis) Sales Volume, Sales Value and Growth Rate of Online Provider (2018-2029)

    • 1.6 China NASH (Non-Alcoholic Steatohepatitis) Market Analysis by Region

      • 1.6.1 North China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate from 2018-2029

    Chapter 2 China NASH (Non-Alcoholic Steatohepatitis) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on NASH (Non-Alcoholic Steatohepatitis) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China NASH (Non-Alcoholic Steatohepatitis) Market Status and Competition Analysis in 2023

      • 2.2.3 China NASH (Non-Alcoholic Steatohepatitis) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China NASH (Non-Alcoholic Steatohepatitis) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on NASH (Non-Alcoholic Steatohepatitis) Industry Development

    Chapter 3 NASH (Non-Alcoholic Steatohepatitis)Industry Chain Analysis

    • 3.1 NASH (Non-Alcoholic Steatohepatitis) Industry Chain

    • 3.2 NASH (Non-Alcoholic Steatohepatitis) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the NASH (Non-Alcoholic Steatohepatitis) Market

    • 3.3 NASH (Non-Alcoholic Steatohepatitis) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the NASH (Non-Alcoholic Steatohepatitis) Market

    Chapter 4 China NASH (Non-Alcoholic Steatohepatitis) Market, by Type

    • 4.1 China NASH (Non-Alcoholic Steatohepatitis) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China NASH (Non-Alcoholic Steatohepatitis) Total Production Volume and Growth Rate from Production Side

    • 4.5 China NASH (Non-Alcoholic Steatohepatitis) Production Volume and Growth Rate, by Type

      • 4.5.1 China NASH (Non-Alcoholic Steatohepatitis) Production Volume and Growth Rate of Elafibranor

      • 4.5.2 China NASH (Non-Alcoholic Steatohepatitis) Production Volume and Growth Rate of Others

      • 4.5.3 China NASH (Non-Alcoholic Steatohepatitis) Production Volume and Growth Rate of Ocaliva

      • 4.5.4 China NASH (Non-Alcoholic Steatohepatitis) Production Volume and Growth Rate of Selonsertib

      • 4.5.5 China NASH (Non-Alcoholic Steatohepatitis) Production Volume and Growth Rate of Vitamin E & Pioglitazone

      • 4.5.6 China NASH (Non-Alcoholic Steatohepatitis) Production Volume and Growth Rate of Cencicriviroc

    Chapter 5 China NASH (Non-Alcoholic Steatohepatitis) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China NASH (Non-Alcoholic Steatohepatitis) Total Market Size and Growth Rate from Consumption End

    • 5.5 China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate, by Application

      • 5.5.1 China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate of Retail Pharmacy

      • 5.5.2 China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate of Hospital Pharmacy

      • 5.5.3 China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate of Online Provider

    Chapter 6 China NASH (Non-Alcoholic Steatohepatitis) Market, by Region

    • 6.1 China NASH (Non-Alcoholic Steatohepatitis) Production Volume and Production Value, by Region

    • 6.2 China NASH (Non-Alcoholic Steatohepatitis) Sales Volume and Sales Value, by Region

    Chapter 7 North China NASH (Non-Alcoholic Steatohepatitis) Market Analysis

    • 7.1 North China NASH (Non-Alcoholic Steatohepatitis) Market, by Type

    • 7.2 North China NASH (Non-Alcoholic Steatohepatitis) Market, by Application

    Chapter 8 Central China NASH (Non-Alcoholic Steatohepatitis) Market Analysis

    • 8.1 Central China NASH (Non-Alcoholic Steatohepatitis) Market, by Type

    • 8.2 Central China NASH (Non-Alcoholic Steatohepatitis) Market, by Application

    Chapter 9 South China NASH (Non-Alcoholic Steatohepatitis) Market Analysis

    • 9.1 South China NASH (Non-Alcoholic Steatohepatitis) Market, by Type

    • 9.2 South China NASH (Non-Alcoholic Steatohepatitis) Market, by Application

    Chapter 10 East China NASH (Non-Alcoholic Steatohepatitis) Market Analysis

    • 10.1 East China NASH (Non-Alcoholic Steatohepatitis) Market, by Type

    • 10.2 East China NASH (Non-Alcoholic Steatohepatitis) Market, by Application

    Chapter 11 Northeast China NASH (Non-Alcoholic Steatohepatitis) Market Analysis

    • 11.1 Northeast China NASH (Non-Alcoholic Steatohepatitis) Market, by Type

    • 11.2 Northeast China NASH (Non-Alcoholic Steatohepatitis) Market, by Application

    Chapter 12 Southwest China NASH (Non-Alcoholic Steatohepatitis) Market Analysis

    • 12.1 Southwest China NASH (Non-Alcoholic Steatohepatitis) Market, by Type

    • 12.2 Southwest China NASH (Non-Alcoholic Steatohepatitis) Market, by Application

    Chapter 13 Northwest China NASH (Non-Alcoholic Steatohepatitis) Market Analysis

    • 13.1 Northwest China NASH (Non-Alcoholic Steatohepatitis) Market, by Type

    • 13.2 Northwest China NASH (Non-Alcoholic Steatohepatitis) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Prometheus Laboratories

        • 14.1.1 Prometheus Laboratories Company Profile

        • 14.1.2 Prometheus Laboratories NASH (Non-Alcoholic Steatohepatitis) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Cadila Pharmaceuticals Ltd

        • 14.2.1 Cadila Pharmaceuticals Ltd Company Profile

        • 14.2.2 Cadila Pharmaceuticals Ltd NASH (Non-Alcoholic Steatohepatitis) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 BioPredictive SAS

        • 14.3.1 BioPredictive SAS Company Profile

        • 14.3.2 BioPredictive SAS NASH (Non-Alcoholic Steatohepatitis) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Novartis AG

        • 14.4.1 Novartis AG Company Profile

        • 14.4.2 Novartis AG NASH (Non-Alcoholic Steatohepatitis) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Intercept Pharmaceuticals, Inc

        • 14.5.1 Intercept Pharmaceuticals, Inc Company Profile

        • 14.5.2 Intercept Pharmaceuticals, Inc NASH (Non-Alcoholic Steatohepatitis) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Genfit SA

        • 14.6.1 Genfit SA Company Profile

        • 14.6.2 Genfit SA NASH (Non-Alcoholic Steatohepatitis) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Laboratory Corporation of America Holdings

        • 14.7.1 Laboratory Corporation of America Holdings Company Profile

        • 14.7.2 Laboratory Corporation of America Holdings NASH (Non-Alcoholic Steatohepatitis) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Galmed Pharmaceuticals

        • 14.8.1 Galmed Pharmaceuticals Company Profile

        • 14.8.2 Galmed Pharmaceuticals NASH (Non-Alcoholic Steatohepatitis) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 One Way Liver, SL

        • 14.9.1 One Way Liver, SL Company Profile

        • 14.9.2 One Way Liver, SL NASH (Non-Alcoholic Steatohepatitis) Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 NASH (Non-Alcoholic Steatohepatitis) Industry Research Conclusions

    • 15.2 NASH (Non-Alcoholic Steatohepatitis) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Industry Market Size (2018-2029)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Production Volume, Production Value and Growth Rate of Elafibranor (2018-2029)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Production Volume, Production Value and Growth Rate of Ocaliva (2018-2029)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Production Volume, Production Value and Growth Rate of Selonsertib (2018-2029)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Production Volume, Production Value and Growth Rate of Vitamin E & Pioglitazone (2018-2029)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Production Volume, Production Value and Growth Rate of Cencicriviroc (2018-2029)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Sales Volume, Sales Value and Growth Rate of Retail Pharmacy (2018-2029)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Sales Volume, Sales Value and Growth Rate of Hospital Pharmacy (2018-2029)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Sales Volume, Sales Value and Growth Rate of Online Provider (2018-2029)

    • Figure North China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate from 2018-2029

    • Figure Central China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate from 2018-2029

    • Figure South China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate from 2018-2029

    • Figure East China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate from 2018-2029

    • Figure NASH (Non-Alcoholic Steatohepatitis) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Market Share by Type in 2018

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Market Share by Type in 2023

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Production Volume and Growth Rate of Elafibranor (2018-2023)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Production Volume and Growth Rate of Others (2018-2023)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Production Volume and Growth Rate of Ocaliva (2018-2023)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Production Volume and Growth Rate of Selonsertib (2018-2023)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Production Volume and Growth Rate of Vitamin E & Pioglitazone (2018-2023)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Production Volume and Growth Rate of Cencicriviroc (2018-2023)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Market Share by Application in 2018

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Market Share by Application in 2023

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Total Market Size and Growth Rate from Consumption End

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate of Retail Pharmacy (2018-2023)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate of Hospital Pharmacy (2018-2023)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Market Size and Growth Rate of Online Provider (2018-2023)

    • Table China NASH (Non-Alcoholic Steatohepatitis) Production Volume by Region (2018-2023)

    • Table China NASH (Non-Alcoholic Steatohepatitis) Production Volume Share by Region (2018-2023)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Production Volume Share by Region (2018-2023)

    • Table China NASH (Non-Alcoholic Steatohepatitis) Production Value by Region (2018-2023)

    • Table China NASH (Non-Alcoholic Steatohepatitis) Production Value Share by Region (2018-2023)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Production Value Share by Region (2018-2023)

    • Table China NASH (Non-Alcoholic Steatohepatitis) Sales Volume by Region (2018-2023)

    • Table China NASH (Non-Alcoholic Steatohepatitis) Sales Volume Share by Region (2018-2023)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Sales Volume Share by Region (2018-2023)

    • Table China NASH (Non-Alcoholic Steatohepatitis) Sales Value by Region (2018-2023)

    • Table China NASH (Non-Alcoholic Steatohepatitis) Sales Value Share by Region (2018-2023)

    • Figure China NASH (Non-Alcoholic Steatohepatitis) Sales Value Share by Region (2018-2023)

    • Table North China NASH (Non-Alcoholic Steatohepatitis) Production Volume by Type (2018-2023)

    • Table North China NASH (Non-Alcoholic Steatohepatitis) Production Volume Share by Type (2018-2023)

    • Figure North China NASH (Non-Alcoholic Steatohepatitis) Production Volume Share by Type (2018-2023)

    • Table North China NASH (Non-Alcoholic Steatohepatitis) Sales Volume by Application (2018-2023)

    • Table North China NASH (Non-Alcoholic Steatohepatitis) Sales Volume Share by Application (2018-2023)

    • Figure North China NASH (Non-Alcoholic Steatohepatitis) Sales Volume Share by Application (2018-2023)

    • Table Central China NASH (Non-Alcoholic Steatohepatitis) Production Volume by Type (2018-2023)

    • Table Central China NASH (Non-Alcoholic Steatohepatitis) Production Volume Share by Type (2018-2023)

    • Figure Central China NASH (Non-Alcoholic Steatohepatitis) Production Volume Share by Type (2018-2023)

    • Table Central China NASH (Non-Alcoholic Steatohepatitis) Sales Volume by Application (2018-2023)

    • Table Central China NASH (Non-Alcoholic Steatohepatitis) Sales Volume Share by Application (2018-2023)

    • Figure Central China NASH (Non-Alcoholic Steatohepatitis) Sales Volume Share by Application (2018-2023)

    • Table South China NASH (Non-Alcoholic Steatohepatitis) Production Volume by Type (2018-2023)

    • Table South China NASH (Non-Alcoholic Steatohepatitis) Production Volume Share by Type (2018-2023)

    • Figure South China NASH (Non-Alcoholic Steatohepatitis) Production Volume Share by Type (2018-2023)

    • Table South China NASH (Non-Alcoholic Steatohepatitis) Sales Volume by Application (2018-2023)

    • Table South China NASH (Non-Alcoholic Steatohepatitis) Sales Volume Share by Application (2018-2023)

    • Figure South China NASH (Non-Alcoholic Steatohepatitis) Sales Volume Share by Application (2018-2023)

    • Table East China NASH (Non-Alcoholic Steatohepatitis) Production Volume by Type (2018-2023)

    • Table East China NASH (Non-Alcoholic Steatohepatitis) Production Volume Share by Type (2018-2023)

    • Figure East China NASH (Non-Alcoholic Steatohepatitis) Production Volume Share by Type (2018-2023)

    • Table East China NASH (Non-Alcoholic Steatohepatitis) Sales Volume by Application (2018-2023)

    • Table East China NASH (Non-Alcoholic Steatohepatitis) Sales Volume Share by Application (2018-2023)

    • Figure East China NASH (Non-Alcoholic Steatohepatitis) Sales Volume Share by Application (2018-2023)

    • Table Northeast China NASH (Non-Alcoholic Steatohepatitis) Production Volume by Type (2018-2023)

    • Table Northeast China NASH (Non-Alcoholic Steatohepatitis) Production Volume Share by Type (2018-2023)

    • Figure Northeast China NASH (Non-Alcoholic Steatohepatitis) Production Volume Share by Type (2018-2023)

    • Table Northeast China NASH (Non-Alcoholic Steatohepatitis) Sales Volume by Application (2018-2023)

    • Table Northeast China NASH (Non-Alcoholic Steatohepatitis) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China NASH (Non-Alcoholic Steatohepatitis) Sales Volume Share by Application (2018-2023)

    • Table Southwest China NASH (Non-Alcoholic Steatohepatitis) Production Volume by Type (2018-2023)

    • Table Southwest China NASH (Non-Alcoholic Steatohepatitis) Production Volume Share by Type (2018-2023)

    • Figure Southwest China NASH (Non-Alcoholic Steatohepatitis) Production Volume Share by Type (2018-2023)

    • Table Southwest China NASH (Non-Alcoholic Steatohepatitis) Sales Volume by Application (2018-2023)

    • Table Southwest China NASH (Non-Alcoholic Steatohepatitis) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China NASH (Non-Alcoholic Steatohepatitis) Sales Volume Share by Application (2018-2023)

    • Table Northwest China NASH (Non-Alcoholic Steatohepatitis) Production Volume by Type (2018-2023)

    • Table Northwest China NASH (Non-Alcoholic Steatohepatitis) Production Volume Share by Type (2018-2023)

    • Figure Northwest China NASH (Non-Alcoholic Steatohepatitis) Production Volume Share by Type (2018-2023)

    • Table Northwest China NASH (Non-Alcoholic Steatohepatitis) Sales Volume by Application (2018-2023)

    • Table Northwest China NASH (Non-Alcoholic Steatohepatitis) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China NASH (Non-Alcoholic Steatohepatitis) Sales Volume Share by Application (2018-2023)

    • Table Prometheus Laboratories Company Profile

    • Table Prometheus Laboratories NASH (Non-Alcoholic Steatohepatitis) Revenue, Price and Gross (2018-2023)

    • Table Cadila Pharmaceuticals Ltd Company Profile

    • Table Cadila Pharmaceuticals Ltd NASH (Non-Alcoholic Steatohepatitis) Revenue, Price and Gross (2018-2023)

    • Table BioPredictive SAS Company Profile

    • Table BioPredictive SAS NASH (Non-Alcoholic Steatohepatitis) Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG NASH (Non-Alcoholic Steatohepatitis) Revenue, Price and Gross (2018-2023)

    • Table Intercept Pharmaceuticals, Inc Company Profile

    • Table Intercept Pharmaceuticals, Inc NASH (Non-Alcoholic Steatohepatitis) Revenue, Price and Gross (2018-2023)

    • Table Genfit SA Company Profile

    • Table Genfit SA NASH (Non-Alcoholic Steatohepatitis) Revenue, Price and Gross (2018-2023)

    • Table Laboratory Corporation of America Holdings Company Profile

    • Table Laboratory Corporation of America Holdings NASH (Non-Alcoholic Steatohepatitis) Revenue, Price and Gross (2018-2023)

    • Table Galmed Pharmaceuticals Company Profile

    • Table Galmed Pharmaceuticals NASH (Non-Alcoholic Steatohepatitis) Revenue, Price and Gross (2018-2023)

    • Table One Way Liver, SL Company Profile

    • Table One Way Liver, SL NASH (Non-Alcoholic Steatohepatitis) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US